hydralazine has been researched along with Tachycardia, Ventricular in 4 studies
Hydralazine: A direct-acting vasodilator that is used as an antihypertensive agent.
hydralazine : The 1-hydrazino derivative of phthalazine; a direct-acting vasodilator that is used as an antihypertensive agent.
Tachycardia, Ventricular: An abnormally rapid ventricular rhythm usually in excess of 150 beats per minute. It is generated within the ventricle below the BUNDLE OF HIS, either as autonomic impulse formation or reentrant impulse conduction. Depending on the etiology, onset of ventricular tachycardia can be paroxysmal (sudden) or nonparoxysmal, its wide QRS complexes can be uniform or polymorphic, and the ventricular beating may be independent of the atrial beating (AV dissociation).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Male patients aged 18-75 years with chronic heart failure were randomized to enalapril or hydralazine-isosorbide dinitrate." | 9.07 | Enalapril decreases prevalence of ventricular tachycardia in patients with chronic congestive heart failure. The V-HeFT II VA Cooperative Studies Group. ( Carson, P; Cintron, GB; Cohn, JN; Fletcher, RD; Johnson, G; Orndorff, J, 1993) |
| "Male patients aged 18-75 years with chronic heart failure were randomized to enalapril or hydralazine-isosorbide dinitrate." | 5.07 | Enalapril decreases prevalence of ventricular tachycardia in patients with chronic congestive heart failure. The V-HeFT II VA Cooperative Studies Group. ( Carson, P; Cintron, GB; Cohn, JN; Fletcher, RD; Johnson, G; Orndorff, J, 1993) |
| "Treatment with captopril significantly reduced the incidence of VT/Vf although hydralazine failed to reduce the incidence." | 1.29 | [Effect of chronic antihypertensive treatment on ischemia-induced lethal ventricular tachyarrhythmias and electrophysiological property in hypertrophied rat hearts]. ( Yokoshiki, H, 1993) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yokoshiki, H | 1 |
| Fletcher, RD | 1 |
| Cintron, GB | 1 |
| Johnson, G | 1 |
| Orndorff, J | 1 |
| Carson, P | 1 |
| Cohn, JN | 1 |
| Ooie, T | 1 |
| Takahashi, N | 1 |
| Saikawa, T | 1 |
| Iwao, T | 1 |
| Hara, M | 1 |
| Sakata, T | 1 |
| Li, D | 1 |
| Shinagawa, K | 1 |
| Pang, L | 1 |
| Leung, TK | 1 |
| Cardin, S | 1 |
| Wang, Z | 1 |
| Nattel, S | 1 |
1 trial available for hydralazine and Tachycardia, Ventricular
| Article | Year |
|---|---|
Enalapril decreases prevalence of ventricular tachycardia in patients with chronic congestive heart failure. The V-HeFT II VA Cooperative Studies Group.
Topics: Death, Sudden, Cardiac; Drug Therapy, Combination; Electrocardiography, Ambulatory; Enalapril; Heart | 1993 |
3 other studies available for hydralazine and Tachycardia, Ventricular
| Article | Year |
|---|---|
[Effect of chronic antihypertensive treatment on ischemia-induced lethal ventricular tachyarrhythmias and electrophysiological property in hypertrophied rat hearts].
Topics: Action Potentials; Animals; Captopril; Drug Administration Schedule; Electrophysiology; Hemodynamics | 1993 |
Suppression of cesium-induced ventricular tachyarrhythmias by atrial natriuretic peptide in rabbits.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Antihypertensive Agents; Atrial Natriuretic Fact | 2000 |
Effects of angiotensin-converting enzyme inhibition on the development of the atrial fibrillation substrate in dogs with ventricular tachypacing-induced congestive heart failure.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Atrial Fibrillation; Dogs; Electr | 2001 |